[1] NABE T.Steroid-resistant asthma and neutrophils[J].Biol Pharm Bull,2020,43(1):31-35.
[2] PANETTIERI R A.The role of neutrophils in asthma[J].Immunology and Allergy Clinics of North America,2018,38(4):629-638.
[3] HAMMAD H,LAMBRECHT B N.The basic immunology of asthma[J].Cell,2021,184(6):1469-1485.
[4] FAEQALI J M,MUNEER A H,HASAN A B,et al.Assessment of interleukin-8 in bronchial asthma in Iraq[J].Arch Razi Inst,2021,76(4):913-923.
[5] MICHAELOUDES C,ABUBAKAR-WAZIRI H,LAKHDAR R,et al.Molecular mechanisms of oxidative stress in asthma[J].Molecular Aspects of Medicine,2022,85:101026.
[6] RACANELLI A C,KIKKERS S A,CHOI A,et al.Autophagy and inflammation in chronic respiratory disease[J].Autophagy,2018,14(2):221-232.
[7] LAMBRECHT B N,HAMMAD H.The airway epithelium in asthma[J].Nature Medicine,2012,18(5):684-692.
[8] RITZMANN F,LUNDING L P,BALS R,et al.IL-17 cytokines and chronic lung diseases[J].Cells,2022,11(14):2132.
[9] HABIB N,PASHA M A,TANG D D.Current understanding of asthma pathogenesis and biomarkers[J].Cells,2022,11(17):2764.
[10] RAMAKRISHNAN R K,AL HEIALY S,HAMID Q.Role of IL-17 in asthma pathogenesis and its implications for the clinic[J].Expert Review of Respiratory Medicine,2019,13(11):1057-1068.
[11] MIZUTANI N,NABE T,YOSHINO S.IL-17A promotes the exacerbation of IL-33-induced airway hyperresponsiveness by enhancing neutrophilic inflammation via CXCR2 signaling in mice[J].J Immunol,2014,192(4):1372-1384.
[12] HALL S L,BAKER T,LAJOIE S,et al.IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation[J].J Allergy Clin Immunol,2017,139(2):462-471.
[13] ZHANG D,YANG H,DONG X L,et al.TL1A/DR3 axis,a key target of TNF-a,augments the epithelial-mesenchymal transformation of epithelial cells in OVA-induced asthma[J].Front Immunol,2022,13:854995.
[14] TAKAYAMA S,TAMAOKA M,TAKAYAMA K,et al.Synthetic double-stranded RNA enhances airway inflammation and remodelling in a rat model of asthma[J].Immunology,2011,134(2):140-150.
[15] BUSSE P J,ZHANG T F,SCHOFIELD B,et al.Decrease in airway mucous gene expression caused by treatment with anti-tumor necrosis factor alpha in a murine model of allergic asthma[J].Ann Allergy Asthma Immunol,2009,103(4):295-303.
[16] YULIANI F S,CHEN J Y,CHENG W H,et al.Thrombin induces IL-8/CXCL8 expression by DCLK1-dependent RhoA and YAP activation in human lung epithelial cells[J].J Biomed Sci,2022,29(1):95.
[17] HA H,DEBNATH B,NEAMATI N.Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases[J].Theranostics,2017,7(6):1543-1588.
[18] MATSUSHIMA K,YANG D,OPPENHEIM J J.Interleukin-8:an evolving chemokine[J].Cytokine,2022,153:155828.
[19] KEGLOWICH L,ROTH M,PHILIPPOVA M,et al.Bronchial smooth muscle cells of asthmatics promote angiogenesis through elevated secretion of CXC-chemokines(ENA-78,GRO-α,and IL-8)[J].PLoS One,2013,8(12):e81494.
[20] GOVINDARAJU V,MICHOUD M C,AL-CHALABI M,et al.Interleukin-8:novel roles in human airway smooth muscle cell contraction and migration[J].Am J Physiol Cell Physiol,2006,291(5):C957-C965.
[21] PHAM D L,BAN G Y,KIM S H,et al.Neutrophil autophagy and extracellular DNA traps contribute to airway inflammation in severe asthma[J].Clin Exp Allergy,2017,47(1):57-70.
[22] HICKS A,MONKARSH S P,HOFFMAN A F,et al.Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease:preclinical and clinical developments[J].Expert Opin Investig Drugs,2007,16(12):1909-1920.
[23] GELFAND E W.Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma[J].Seminars in Immunology,2017,33:44-51.
[24] NAKAMURA M,SHIMIZU T.Recent advances in function and structure of two leukotriene B(4) receptors:BLT1 and BLT2[J].Biochem Pharmacol,2022,203:115178.
[25] YOKOMIZO T,NAKAMURA M,SHIMIZU T.Leukotriene receptors as potential therapeutic targets[J].J Clin Invest,2018,128(7):2691-2701.
[26] DAKHAMA A,COLLINS M L,OHNISHI H,et al.IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction[J].Allergy,2013,68(5):666-673.
[27] DÖMER D,WALTHER T,MÖLLER S,et al.Neutrophil extracellular traps activate proinflammatory functions of human neutrophils[J].Front Immunol,2021,12:636954.
[28] VARRICCHI G,MODESTINO L,POTO R,et al.Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma[J].Clin Exp Med,2022,22(2):285-300.
[29] POTO R,SHAMJI M,MARONE G,et al.Neutrophil extracellular traps in asthma:friends or foes?[J].Cells,2022,11(21):3521.
[30] LACHOWICZ-SCROGGINS M E,DUNICAN E M,CHARBIT A R,et al.Extracellular DNA,neutrophil extracellular traps,and inflammasome activation in severe asthma[J].Am J Respir Crit Care Med,2019,199(9):1076-1085.
[31] HAN X A,JIE H Y,WANG J H,et al.Necrostatin-1 ameliorates neutrophilic inflammation in asthma by suppressing MLKL phosphorylation to inhibiting NETs release[J].Front Immunol,2020,11:666.
[32] COMHAIR S A,ERZURUM S C.Redox control of asthma:molecular mechanisms and therapeutic opportunities[J].Antioxid Redox Signal,2010,12(1):93-124.
[33] LIU K,HUA S,SONG L.PM2.5 exposure and asthma development:the key role of oxidative stress[J].Oxid Med Cell Longev,2022,2022:3618806.
[34] HU X,SHEN Y,ZHAO Y,et al.Epithelial Aryl hydrocarbon receptor protects from mucus production by inhibiting ROS-triggered NLRP3 inflammasome in asthma[J].Front Immunol,2021,12:767508.
[35] WHITEHEAD G S,THOMAS S Y,NAKANO K,et al.A neutrophil/TGF-β axis limits the pathogenicity of allergen-specific CD4+ T cells[J].JCI Insight,2022,7(4):e150251.
[36] SAITO A,HORIE M,NAGASE T.TGF-β signaling in lung health and disease[J].Int J Mol Sci,2018,19(8):2460.
[37] JENDZJOWSKY N G,KELLY M M.The role of airway myofibroblasts in asthma[J].Chest,2019,156(6):1254-1267.
[38] LIU G,PHILP A M,CORTE T,et al.Therapeutic targets in lung tissue remodelling and fibrosis[J].Pharmacol Ther,2021,225:107839.
[39] RIEMMA M A,CERQUA I,ROMANO B,et al.Sphingosine-1-phosphate/TGF-β axis drives epithelial mesenchymal transition in asthma-like disease[J].Br J Pharmacol,2022,179(8):1753-1768.
[40] ZOU F,ZHANG J,XIANG G,et al.Association of matrix metalloproteinase 9(MMP-9) polymorphisms with asthma risk:a Meta-analysis[J].Can Respir J,2019,2019:9260495.
[41] CHUNG F T,HUANG H Y,LO C Y,et al.Increased ratio of matrix metalloproteinase-9(MMP-9)/tissue inhibitor metalloproteinase-1 from alveolar macrophages in chronic asthma with a fast decline in FEV(1) at 5-year follow-up[J].J Clin Med,2019,8(9):1451.
[42] VIEIRA C P,DE OLIVEIRA L P,DA S M,et al.Role of metalloproteinases and TNF-α in obesity-associated asthma in mice[J].Life Sci,2020,259:118191.
[43] WU X L,LI R,ZHANG H W,et al.Methylation status of ORMDL3 regulates cytokine production and p-ERK/MMP9 pathway expression[J].Exp Cell Res,2018,372(1):43-51.
[44] DING Z,YU F,SUN Y,et al.ORMDL3 promotes angiogenesis in chronic asthma through the ERK1/2/VEGF/MMP-9 pathway[J].Front Pediatr,2021,9:708555.
[45] DUAN X J,ZHANG X,LI L R,et al.MiR-200a and miR-200b restrain inflammation by targeting ORMDL3 to regulate the ERK/MMP-9 pathway in asthma[J].Exp Lung Res,2020,46(9):321-331.
[46] YU F,SUN Y,YU J,et al.ORMDL3 is associated with airway remodeling in asthma via the ERK/MMP-9 pathway[J].Mol Med Rep,2017,15(5):2969-2976. |
